Use of Medications and Other Treatments for Obesity: Multidisciplinary and Individualized Management
DOI:
https://doi.org/10.5281/zenodo.22014322Palabras clave:
obesity treatment; pharmacotherapy; multidisciplinary care; individualized management; chronic disease; public health.Resumen
Obesity is a chronic and multifactorial disease that requires comprehensive therapeutic approaches combining lifestyle interventions, pharmacological treatments, behavioral strategies, and, when indicated, surgical procedures. The increasing prevalence of obesity and its association with chronic noncommunicable diseases have intensified the need for healthcare models capable of providing effective, continuous, and individualized management. Pharmacological therapies have expanded the possibilities for obesity treatment, offering additional resources for individuals who do not achieve adequate outcomes through lifestyle interventions alone. The use of medications for obesity management represents an important component of modern therapeutic strategies, but their effectiveness depends on appropriate clinical evaluation, individualized decision-making, monitoring, and integration with multidisciplinary care. Treatment should not be limited to weight reduction but should aim to improve metabolic health, quality of life, functional capacity, and prevention of obesity-related complications. This academic essay discusses the use of medications and other therapeutic approaches for obesity management, emphasizing multidisciplinary and individualized care. The discussion explores pharmacological treatment, behavioral interventions, nutritional strategies, physical activity, surgical approaches, and challenges related to healthcare organization. The manuscript argues that effective obesity treatment requires integrated approaches that combine scientific evidence, patient preferences, professional collaboration, and long-term follow-up.
Referencias
American Gastroenterological Association. (2022). AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology, 163(5), 1190–1200.
Apovian, C. M. (2016). Obesity: Definition, comorbidities, causes, and burden. The American Journal of Managed Care, 22(7 Suppl), s176–s185.
Bray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016). Management of obesity. The Lancet, 387(10031), 1947–1956.
Bray, G. A., Kim, K. K., & Wilding, J. P. H. (2017). Obesity: A chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obesity Reviews, 18(7), 715–723.
Dombrowski, S. U., Knittle, K., Avenell, A., Araujo-Soares, V., & Sniehotta, F. F. (2014). Long term maintenance of weight loss with non-surgical interventions in obese adults: Systematic review and meta-analyses. BMJ, 348, g2646.
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., et al. (2016). American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice, 22(Suppl 3), 1–203.
Gadde, K. M., Martin, C. K., Berthoud, H. R., & Heymsfield, S. B. (2018). Obesity: Pathophysiology and management. Journal of the American College of Cardiology, 71(1), 69–84.
Hall, K. D., & Kahan, S. (2018). Maintenance of lost weight and long-term management of obesity. Medical Clinics of North America, 102(1), 183–197.
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., et al. (2014). 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation, 129(25 Suppl 2), S102–S138.
Mendes, E. V. (2019). Desafios do SUS. Conselho Nacional de Secretários de Saúde.
Paim, J., Travassos, C., Almeida, C., Bahia, L., & Macinko, J. (2011). The Brazilian health system: History, advances, and challenges. The Lancet, 377(9779), 1778–1797.
Rubino, F., Puhl, R. M., Cummings, D. E., Eckel, R. H., Ryan, D. H., Mechanick, J. I., et al. (2020). Joint international consensus statement for ending stigma of obesity. Nature Medicine, 26, 485–497.
Swinburn, B. A., Kraak, V. I., Allender, S., Atkins, V. J., Baker, P. I., Bogard, J. R., et al. (2019). The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. The Lancet, 393(10173), 791–846.
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989–1002.
World Health Organization. (2022). Obesity: Preventing and managing the global epidemic. World Health Organization.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Journal of Social Issues and Health Sciences (JSIHS)

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
